Medivir AB (MVIRb.F): Webcast Presentation of Simeprevir Phase III Clinical Data
5/3/2013 11:12:36 AM
Staying up-to-date has never been simpler. Sign up for the free
GenePool newsletter today!
HUDDINGE, Sweden--(BUSINESS WIRE)--Medivir AB (STO:MVIR-B) today announces that Janssen R&D Ireland and Johnson & Johnson will provide a pre-recorded webcast for investors and other interested parties on Friday, May 3, at approximately 8:30 a.m., Eastern Time (14.30 CET), to discuss simeprevir phase III clinical data presented at The International Liver Congress of the European Association for the Study of the Liver (EASL).
Help employers find you! Check out all the jobs and post your resume.
comments powered by